Posted by
Tolerability and Safety of Theta-Burst TMS in Patients with Major Depression

Tolerability and Safety of Theta-Burst TMS in Patients with Major Depression

Abstract The aim of this open study was to evaluate the safety and tolerability of theta-burst transcranial magnetic stimulation (TBS) and to assess preliminarily its therapeutic efficacy in patients with major depression. A total of 33 patients were assigned to receive one of four TBS protocols for 10 consecutive work days. TBS consisted of triple-pulse […]

Posted by
FDA grants 510k clearance to MagVita TMS

FDA grants 510k clearance to MagVita TMS

The FDA recently granted 510k clearance to market MagVita TMS therapy, a repetitive transcranial magnetic stimulation system, for treatment of depression. “The new FDA cleared MagVita TMS Therapy system is tailor-made for health care professionals seeking an entry-level TMS system without having to compromise on quality and safety,” Kerry Rome, BS, vice president of sales […]